| 000 | 01715 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515153607.0 | ||
| 264 | 0 | _c20090421 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a1542-233X | ||
| 024 | 7 |
_a10.1097/ICL.0b013e318193a3df _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNichols, Kelly K | |
| 245 | 0 | 0 |
_aEpinastine 0.05% ophthalmic solution in contact lens-wearing subjects with a history of allergic conjunctivitis. _h[electronic resource] |
| 260 |
_bEye & contact lens _cJan 2009 |
||
| 300 |
_a26-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aConjunctivitis, Allergic _xcomplications |
| 650 | 0 | 4 |
_aContact Lenses _xadverse effects |
| 650 | 0 | 4 |
_aDibenzazepines _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEye Diseases _xetiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHistamine H1 Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMedical Records |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOphthalmic Solutions |
| 650 | 0 | 4 |
_aPruritus _xetiology |
| 650 | 0 | 4 | _aSeasons |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aWetting Agents _xadministration & dosage |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMorris, Scot | |
| 700 | 1 | _aGaddie, Ian B | |
| 700 | 1 | _aEvans, David | |
| 773 | 0 |
_tEye & contact lens _gvol. 35 _gno. 1 _gp. 26-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/ICL.0b013e318193a3df _zAvailable from publisher's website |
| 999 |
_c18574518 _d18574518 |
||